Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Can B cell-deficient patients rely on COVID-19 vaccine-induced T-cell immunity?
1Stanford University School of Medicine, Stanford, CA, USA.
Anti-CD20 antibody treatments prevent humoral responses to vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines, but the nature of T-cell responses in this setting is less well understood. Riise et al. assess vaccine-induced epitope-specific CD8 T cell responses in patients with lymphoma recently treated with rituximab and find a wide range of responses, with the most recently treated patients frequently failing to respond, while others exhibit responses stronger than healthy controls. They suggest these epitopes among others could be used in a T cell-targeted vaccine, and such strategies are indeed in clinical trials now. Commentary on: Riise J, et al. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. Br J Haematol. 2022;197:697-708.
Anti-CD20 antibody treatments prevent humoral responses to vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines, but the nature of T-cell responses in this setting is less well understood. Riise et al. assess vaccine-induced epitope-specific CD8 T cell responses in patients with lymphoma recently treated with rituximab and find a wide range of responses, with the most recently treated patients frequently failing to respond, while others exhibit responses stronger than healthy controls. They suggest these epitopes among others could be used in a T cell-targeted vaccine, and such strategies are indeed in clinical trials now. Commentary on: Riise J, et al. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. Br J Haematol. 2022;197:697-708.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Vaccinations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

